Moody's Rating for Regeneus

MOODY'S ANALYTICS RISK SCORE

5

Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Regeneus Ltd. is regenerative medicine company. It develops and commercializes innovative cell-based therapies to address unmet medical needs in human and veterinary health. The company was founded by Ben Herbert and Graham Vesey on August 14, 2007 and is headquartered in Pymble, Australia.